TABLE 1 Global Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 2 Global Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 3 Global Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 4 Global Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 5 Global Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 6 Global Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 7 Global Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 8 Global Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 9 North America Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 10 North America Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 11 North America Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 12 North America Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 13 North America Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 14 North America Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 15 North America Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 16 North America Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 17 U.S. Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 18 U.S. Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 19 U.S. Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 20 U.S. Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 21 U.S. Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 22 U.S. Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 23 U.S. Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 24 U.S. Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 25 Canada Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 26 Canada Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 27 Canada Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 28 Canada Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 29 Canada Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 30 Canada Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 31 Canada Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 32 Canada Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 33 Rest of North America Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 34 Rest of North America Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 35 Rest of North America Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 36 Rest of North America Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 37 Rest of North America Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 38 Rest of North America Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 39 Rest of North America Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 40 Rest of North America Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 41 UK and European Union Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 42 UK and European Union Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 43 UK and European Union Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 44 UK and European Union Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 45 UK and European Union Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 46 UK and European Union Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 47 UK and European Union Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 48 UK and European Union Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 49 UK Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 50 UK Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 51 UK Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 52 UK Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 53 UK Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 54 UK Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 55 UK Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 56 UK Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 57 Germany Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 58 Germany Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 59 Germany Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 60 Germany Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 61 Germany Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 62 Germany Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 63 Germany Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 64 Germany Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 65 Spain Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 66 Spain Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 67 Spain Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 68 Spain Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 69 Spain Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 70 Spain Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 71 Spain Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 72 Spain Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 73 Italy Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 74 Italy Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 75 Italy Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 76 Italy Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 77 Italy Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 78 Italy Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 79 Italy Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 80 Italy Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 81 France Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 82 France Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 83 France Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 84 France Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 85 France Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 86 France Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 87 France Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 88 France Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 89 Rest of Europe Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 90 Rest of Europe Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 91 Rest of Europe Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 92 Rest of Europe Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 93 Rest of Europe Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 94 Rest of Europe Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 95 Rest of Europe Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 96 Rest of Europe Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 97 Asia Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 98 Asia Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 99 Asia Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 100 Asia Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 101 Asia Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 102 Asia Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 103 Asia Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 104 Asia Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 105 China Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 106 China Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 107 China Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 108 China Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 109 China Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 110 China Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 111 China Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 112 China Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 113 Japan Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 114 Japan Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 115 Japan Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 116 Japan Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 117 Japan Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 118 Japan Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 119 Japan Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 120 Japan Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 121 India Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 122 India Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 123 India Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 124 India Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 125 India Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 126 India Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 127 India Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 128 India Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 129 Australia Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 130 Australia Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 131 Australia Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 132 Australia Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 133 Australia Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 134 Australia Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 135 Australia Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 136 Australia Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 137 South Korea Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 138 South Korea Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 139 South Korea Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 140 South Korea Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 141 South Korea Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 142 South Korea Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 143 South Korea Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 144 South Korea Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 145 Latin America Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 146 Latin America Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 147 Latin America Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 148 Latin America Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 149 Latin America Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 150 Latin America Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 151 Latin America Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 152 Latin America Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 153 Brazil Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 154 Brazil Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 155 Brazil Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 156 Brazil Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 157 Brazil Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 158 Brazil Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 159 Brazil Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 160 Brazil Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 161 Mexico Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 162 Mexico Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 163 Mexico Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 164 Mexico Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 165 Mexico Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 166 Mexico Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 167 Mexico Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 168 Mexico Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 169 Rest of Latin America Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 170 Rest of Latin America Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 171 Rest of Latin America Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 172 Rest of Latin America Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 173 Rest of Latin America Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 174 Rest of Latin America Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 175 Rest of Latin America Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 176 Rest of Latin America Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 177 Middle East and Africa Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 178 Middle East and Africa Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 179 Middle East and Africa Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 180 Middle East and Africa Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 181 Middle East and Africa Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 182 Middle East and Africa Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 183 Middle East and Africa Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 184 Middle East and Africa Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 185 GCC Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 186 GCC Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 187 GCC Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 188 GCC Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 189 GCC Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 190 GCC Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 191 GCC Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 192 GCC Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 193 Africa Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 194 Africa Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 195 Africa Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 196 Africa Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 197 Africa Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 198 Africa Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 199 Africa Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 200 Africa Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)
TABLE 201 Rest of Middle East and Africa Polymyositis Treatment Market By Type of Drug Class, 2023-2033, USD (Million)
TABLE 202 Rest of Middle East and Africa Polymyositis Treatment Market By Immunosuppressant, 2023-2033, USD (Million)
TABLE 203 Rest of Middle East and Africa Polymyositis Treatment Market By Alkylating Agent, 2023-2033, USD (Million)
TABLE 204 Rest of Middle East and Africa Polymyositis Treatment Market By Monoclonal Antibodies, 2023-2033, USD (Million)
TABLE 205 Rest of Middle East and Africa Polymyositis Treatment Market By Corticosteroids, 2023-2033, USD (Million)
TABLE 206 Rest of Middle East and Africa Polymyositis Treatment Market By Pipeline Analysis, 2023-2033, USD (Million)
TABLE 207 Rest of Middle East and Africa Polymyositis Treatment Market By Phase III (Sales till 2029; US$ Mn), 2023-2033, USD (Million)
TABLE 208 Rest of Middle East and Africa Polymyositis Treatment Market By Phase I & II (Qualitative Information), 2023-2033, USD (Million)